MET and breast cancer: In their gene candidate studies, Finegold and coworkers [28] found HGF and cMET mutations in single subjects with primary lymphedema, lymphangiectasia, and breast cancer-related lymphedema (BCRL) subjects that were not polymorphic in control populations.